TAPUR

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

TAPUR

Sep 29, 2024, 18:33 | Blog

Allen Chankowsky: Proud to announce that I’ll be the patient keynote at Clinical Trials Ontario annual conference

Allen Chankowsky, Owner, MBC Marketing, shared a post on LinkedIn: "Proud to announce that I’ll…

May 17, 2024, 12:54 | Insight

Piotr Wysocki: Anti-HER2 treatment in patients with advanced biliary cancer

Piotr Wysocki recently posted on LinkedIn: "The Targeted Agent and Profiling Utilization Registry (TAPUR) Study is…

Apr 22, 2024, 16:41 | Blog

Robin Zon: Thank you to Manmeet Ahluwalia for inviting me to speak about ASCO’s incredible TAPUR work!

Robin Zon, President Elect at ASCO and Chair of South Bend Medical Foundation, shared on…

Apr 11, 2024, 17:43 | Societies

Mark your calendars for our upcoming virtual Grand Rounds to explore the use of Precision Medicine through the TAPUR Study - ASCO

American Society of Clinical Oncology (ASCO) shared a post LinkedIn: “Mark your calendars for our…

Jun 15, 2023, 15:56 | Drugs

Patients with ERBB2 exon 20 insertion mutations showed particularly encouraging outcomes - Elie G. Dib

Excited to share that our study, published in JCO Precision Oncology, sheds light on the…

All: 5 Posts: 1 - 100